The Patent Finder

Crescendo Biologics Limited

13 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

0
Ending by 2030
Jan 2035
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 6, 2026
    The maintenance fee for IL-17A binding proteins (US 11,667,705) comes due Dec 6, 2026. Unpaid by Jun 7, 2027, it lapses early.
  • 2 fees due Mar 3 to 5, 2027 · next Mar 3
  • 1 fee due May 14, 2027
    The maintenance fee for Single Domain Antibodies to Programmed Cell Death (PD-1) (US 11,814,429) comes due May 14, 2027. Unpaid by Nov 15, 2027, it lapses early.
  • 1 fee due Jul 9, 2027
    The maintenance fee for Chimeric Antigen Receptor with Single Domain Antibody (US 11,866,510) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.
  • 1 fee due Oct 9, 2027
    The maintenance fee for Therapeutic Molecules That Bind to LAG3 and PD1 (US 11,951,172) comes due Oct 9, 2027. Unpaid by Apr 10, 2028, it lapses early.
  • 1 fee due Nov 19, 2027
    The maintenance fee for IL-17A binding proteins (US 10,654,924) comes due Nov 19, 2027. Unpaid by May 19, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,547,099Transgenic Mice
In force
 · High confidence
In forceHigh confidence
US 10,654,924IL-17A binding proteins
In force
 · USPTO record
In forceUSPTO record
US 10,400,030Methods for Producing Optimised Therapeutic Molecules
In force
 · High confidence
In forceHigh confidence
US 11,746,158Therapeutic Molecules
In force
 · High confidence
In forceHigh confidence
US 11,667,705IL-17A binding proteins
In force
 · USPTO record
In forceUSPTO record
US 11,866,510Chimeric Antigen Receptor with Single Domain Antibody
In force
 · High confidence
In forceHigh confidence
US 10,975,161Molecules that Bind Prostate Specific Membrane Antigen (PSMA)
In force
 · High confidence
In forceHigh confidence
US 10,947,308Composition for treatment of disorders
In force
 · USPTO record
In forceUSPTO record
US 11,591,398Single Domain Antibodies to Programmed Cell Death Protein 1 (PD-1)
In force
 · High confidence
In forceHigh confidence
US 11,814,429Single Domain Antibodies to Programmed Cell Death (PD-1)
In force
 · Medium confidence
In forceMedium confidence
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
Also on record, not counted in the 13: 8 lapsed for an unpaid fee · 6 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 1 abandoned · 13 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited